Protection from endotoxic uveitis by intravitreal resolvin D1: Involvement of lymphocytes, miRNAs, ubiquitin-proteasome, and M1/M2 macrophages

Mediators of Inflammation

Volumn 2015, Issue , 2015, Pages

  Rossi, S ^a   Di Filippo, C ^a   Gesualdo, C ^a   Potenza, N ^a   Russo, A ^a   Trotta, M C ^a   Zippo, M V ^a   Maisto, R ^a   Ferraraccio, F ^a   Simonelli, F ^a   D'Amico, M ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MICRORNA; MICRORNA 200C 3P; MICRORNA 203A 3P; MICRORNA 21 5P; MICRORNA 29B 3P; PROTEASOME; RESOLVIN D1; RNA; TUMOR NECROSIS FACTOR ALPHA; UBIQUITIN; UNCLASSIFIED DRUG; DOCOSAHEXAENOIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; DOSE RESPONSE; ENDOTOXIC UVEITIS; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; T LYMPHOCYTE; UPREGULATION; UVEITIS; ANIMAL; DRUG EFFECTS; ENZYME LINKED IMMUNOSORBENT ASSAY; INTRAVITREAL DRUG ADMINISTRATION; LYMPHOCYTE; METABOLISM; REAL TIME POLYMERASE CHAIN REACTION; SPRAGUE DAWLEY RAT;

RATTUS; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR MINNESOTA;

ANIMALS; DOCOSAHEXAENOIC ACIDS; ENZYME-LINKED IMMUNOSORBENT ASSAY; IMMUNOHISTOCHEMISTRY; INTRAVITREAL INJECTIONS; LYMPHOCYTES; MACROPHAGES; MALE; PROTEASOME ENDOPEPTIDASE COMPLEX; RATS; RATS, SPRAGUE-DAWLEY; REAL-TIME POLYMERASE CHAIN REACTION; UBIQUITIN; UVEITIS;

EID: 84947648655     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2015/149381     Document Type: Article

References (37)

1. J. Deschenes, P. I. Murray, N. A. Rao, and International Uveitis Study Group, "International Uveitis Study Group: clinical classification of uveitis, " Ocular Immunology andInflammation, vol. 16, no. 1, pp. 1-2, 2008.
2. A. D. Dick, "The treatment of chronic uveiticmacular oedema., " British Journal of Ophthalmology, vol. 78, no. 1, pp. 1-2, 1994.
3. W. A. Franks, G. A. Limb, M. R. Stanford et al., "Cytokines in human intraocular inflammation, " Current Eye Research, vol. 11, pp. 187-191, 1992.
4. S. Rossi, D. F. Clara, F. Franca, S. Francesca, and D. Michele, "Resolvin D1 reduces the immunoinflammatory response of the rat eye following uveitis, " Mediators of Inflammation, vol. 2012, Article ID 318621, 9 pages, 2012.
5. E. C. Ebert, "Infliximab and the TNF-alpha system, " American Journal of Physiology-Gastrointestinal and Liver Physiology, vol. 296, no. 3, pp. G612-G620, 2009.
6. S. H. Hosseini and E. Salehifar, "Social phobia following maprotiline: the first case report, " Cases Journal, vol. 2, no. 12, article 9340, 2009.
7. T. Demir, A. Gödekmerdan, M. Balbaba, P. Türkcüoglu, F. Ilhan, and N. Demir, "The effect of infliximab, cyclosporine A and recombinant IL-10 on vitreous cytokine levels in experimental autoimmune uveitis, " Indian Journal of Ophthalmology, vol. 54, no. 4, pp. 241-245, 2006.
8. T. R. Thrimawithana, S. Young, C. R. Bunt, C. Green, and R. G. Alany, "Drug delivery to the posterior segment of the eye, " Drug Discovery Today, vol. 16, no. 5-6, pp. 270-277, 2011.
9. Y.-P. Sun, S. F. Oh, J. Uddin et al., "Resolvin D1 and its aspirin-triggered 17epimer: stereochemical assignments, antiinflammatory properties, and enzymatic inactivation, "TheJournal of Biological Chemistry, vol. 282, no. 13, pp. 9323-9334, 2007.
10. F. Chen, Z. Xie, X. Wu et al., "Intravitreal injection of soluble erythropoietin receptor exacerbates photoreceptor cell apoptosis in a rat model of retinal detachment, " Current Eye Research, vol. 37, no. 12, pp. 1156-1164, 2012.
11. L. L. Tian, B. Ren, X. W. Gao et al., "Inhibition of retinopathy of prematurity in rat by intravitreal injection of sorafenib, " International Journal of Ophthalmology, vol. 7, no. 2, pp. 198-204, 2014.
12. M. R. Romano, F. Biagioni, G. Besozzi et al., "Effects of bevacizumab on neuronal viability of retinal ganglion cells in rats, " Brain Research, vol. 1478, pp. 55-63, 2012.
13. A. L. Alessandri, L. P. Sousa, C. D. Lucas, A. G. Rossi, V. Pinho, and M. M. Teixeira, "Resolution of inflammation: mechanisms and opportunity for drug development, " Pharmacology and Therapeutics, vol. 139, no. 2, pp. 189-212, 2013.
14. C. Cuello, D. Wakefield, and N. Di Girolamo, "Neutrophil accumulation correlates with type IV collagenase/gelatinase activity in endotoxin induced uveitis, " British Journal of Ophthalmology, vol. 86, no. 3, pp. 290-295, 2002.
15. A. M. Vicente, M. I. Guillén, and M. J. Alcaraz, "Participation of heme oxygenase-1 in a model of acute inflammation, " Experimental Biology and Medicine, vol. 228, no. 5, pp. 514-516, 2003.
16. S. Riviere, L. Challet, D. Fluegge, M. Spehr, and I. Rodriguez, "Formyl peptide receptor-like proteins are a novel family of vomeronasal chemosensors, " Nature, vol. 459, no. 7246, pp. 574-577, 2009.
17. O. Odusanwo, S. Chinthamani, A. McCall, M. E. Duffey, and O. J. Baker, "Resolvin D1 prevents TNF-mediated disruption of salivary epithelial formation, " American Journal of Physiology-Cell Physiology, vol. 302, no. 9, pp. C1331-C1345, 2012.
18. B. D. Levy, "Resolvins and protectins: natural pharmacophores for resolution biology, " Prostaglandins Leukotrienes and Essential Fatty Acids, vol. 82, no. 4-6, pp. 327-332, 2010.
19. C. J. Loscher, K. Hokamp, J. H. Wilson et al., "A common microRNA signature in mouse models of retinal degeneration, " Experimental Eye Research, vol. 87, no. 6, pp. 529-534, 2008.
20. C. J. Loscher, K. Hokamp, P. F. Kenna et al., "Altered retinal microRNA expression profile in a mouse model of retinitis pigmentosa, " Genome Biology, vol. 8, no. 11, article R248, 2007.
21. W. Ishida, K. Fukuda, T. Higuchi, M. Kajisako, S. Sakamoto, and A. Fukushima, "Dynamic changes of microRNAs in the eye during the development of experimental autoimmune uveoretinitis, " Investigative Ophthalmology and Visual Science, vol. 52, no. 1, pp. 611-617, 2011.
22. S. Xu, "microRNA expression in the eyes and their significance in relation to functions, " Progress in Retinal and Eye Research, vol. 28, no. 2, pp. 87-116, 2009.
23. S. K.-W. Lee, Y. Teng, H.-K. Wong et al., "MicroRNA-145 regulates human corneal epithelial differentiation, " PLoS ONE, vol. 6, Article ID e21249, 2011.
24. K. Conkrite, M. Sundby, S. Mukai et al., "Mir-1792 cooperates with RB pathway mutations to promote retinoblastoma, " Genes and Development, vol. 25, no. 16, pp. 1734-1745, 2011.
25. A. di Francesco, C. de Pitta, F. Moret, V. Barbieri, L. Celotti, and M. Mognato, "The DNA-Damage Response to-radiation is affected by miR-27a in A549 cells, " International Journal of Molecular Sciences, vol. 14, no. 9, pp. 17881-17896, 2013.
26. B. Hoesel and J. A. Schmid, "Thecomplexity of NF-B signaling in inflammation and cancer, " Molecular Cancer, vol. 12, article 86, 2013.
27. S. Bae, E.-J. Lee, J. H. Lee et al., "Oridonin protects HaCaT keratinocytes against hydrogen peroxide-induced oxidative stress by altering microRNA expression, " International Journal of Molecular Medicine, vol. 33, no. 1, pp. 185-193, 2014.
28. S. D. Varma and S. Kovtun, "Protective effect of caffeine against high sugar-induced transcription of microRNAand consequent gene silencing: a study using lenses of galactosemic mice, " Molecular Vision, vol. 19, pp. 493-500, 2013.
29. X. Ma, L. E. B. Buscaglia, J. R. Barker, and Y. Li, "MicroRNAs in NF-B signaling, " Journal ofMolecular Cell Biology, vol. 3, no. 3, pp. 159-166, 2011.
30. C. E. Monk, G. Hutvagner, and J. S. C. Arthur, "Regulation of miRNA transcription in macrophages in response to Candida albicans, " PLoS ONE, vol. 5, no. 10, Article IDe13669, 2010.
31. A. Sallam, S. R. J. Taylor, and S. Lightman, "Review and update of intraocular therapy in noninfectious uveitis, " Current Opinion in Ophthalmology, vol. 22, no. 6, pp. 517-522, 2011.
32. S. R. J. Taylor, H. Isa, L. Joshi, and S. Lightman, "New developments in corticosteroid therapy for uveitis, " Ophthalmologica, vol. 224, no. 1, pp. 46-53, 2010.
33. J. Reis, F. Hassan, X. Q. Guan et al., "The immunoproteasomes regulate LPS-induced TRIF/TRAM signaling pathway in murine macrophages, " Cell Biochemistry and Biophysics, vol. 60, no. 1-2, pp. 119-126, 2011.
34. S. Bunda, K. Kommaraju, P. Heir, and M. Ohh, "SOCS-1 mediates ubiquitylation and degradation of GM-CSF receptor, " PLoS ONE, vol. 8, no. 9, Article ID e76370, 2013.
35. K. Kimura and T. Nishida, "Role of the ubiquitin-proteasome pathway in downregulation of the gap-junction protein connexin43 by TNF-in human corneal fibroblasts, " Investigative Ophthalmology and Visual Science, vol. 51, no. 4, pp. 1943-1947, 2010.
36. X. YuandD. C. Kem, "Proteasome inhibitionduringmyocardial infarction, " Cardiovascular Research, vol. 85, no. 2, pp. 312-320, 2010.
37. Z. Zemeckiene, A. Vitkauskiene, T. Sjakste, B. Sitkauskiene, and R. Sakalauskas, "Proteasomes and proteasomal gene polymorphism in association with inflammation and various diseases, " Medicina, vol. 49, no. 5, pp. 207-213, 2013.